Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study. [electronic resource]
- Transplant international : official journal of the European Society for Organ Transplantation 05 2018
- 503-509 p. digital
Publication Type: Journal Article
1432-2277
10.1111/tri.13112 doi
Aged Antiviral Agents--therapeutic use DNA, Viral--analysis Female Hepatitis B--prevention & control Hepatitis B Surface Antigens--blood Humans Immunoglobulins--administration & dosage Injections, Subcutaneous Liver Transplantation--adverse effects Male Middle Aged Prospective Studies Renal Insufficiency--prevention & control